Comparing a new insulin combo with premixed insulin for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had type 2 diabetes for at least 6 months
- You have been using premixed insulin (with or without other diabetes pills, but not certain types) for 3 months or more, and your blood sugar is still not well controlled
- Your A1C (average blood sugar over 3 months) is between 7.0% and 8.0%
- Your body mass index (BMI) is between 18 and 35
- You are willing to use a blood sugar monitor at home as directed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This study tests a combination insulin/GLP-1 medicine (iGlarLixi) with continuous glucose monitoring to see how well it controls blood sugar in Chinese adults with type 2 diabetes. It may help those whose current pills are not working enough.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This trial tests a new combination pen (insulin degludec with liraglutide) for people with type 2 diabetes whose blood sugar is not well controlled on metformin alone or with one other pill. The goal is to see if the combination improves blood sugar control safely.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
Hear when a new Type 2 Diabetic Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.